Ovarian Cancer

<< Back

Headlines: (Click on headline for full article)

• Ovarian cancer screening still gets thumbs down
  Reuters 10 Sep 2012 15:02 PM PDT NEW YORK (Reuters Health)
  There is no evidence that getting screened for ovarian cancer helps women beat the dread disease, according to updated recommendations from a U.S. government-backed expert panel. The U.S. Preventive Services Task Force (USPSTF) said it continues to discourage screening in women at average risk, adding that there is no reason to believe women at higher risk would ...
• Avastin May Help Fight Tough-to-Treat Ovarian Tumors Study found it slightly lengthened the time before the cancer returned
  By Amanda Gardner HealthDay Reporter SATURDAY, June 2 (HealthDay News)
  French researchers report that a targeted therapy already enlisted in the fight against colorectal cancer, lung cancer and kidney cancer may also have a role to play in recalcitrant ovarian cancer.
• Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case ...
  Lancet Tue, 21 Feb 2012 16:14 PM PST
  Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear.
• Gene Mutations May Boost Ovarian Cancer Survival: Study
  HealthDay via Yahoo! News Tue, 24 Jan 2012 16:12 PM PST
  Genetic mutations known as BRCA1 and BRCA2 raise the risk of getting ovarian cancer, but new research shows that those same mutations may boost a woman's odds of surviving the deadly disease.
• Avastin May Help Some With Ovarian Cancer: Studies Survival without disease getting worse rose slightly, but benefit on overall survival remains unclear
  By Serena Gordon HealthDay Reporter - WEDNESDAY, Dec. 28 (HealthDay News)
  Two new studies suggest that the drug Avastin may lengthen progression-free survival by about four months for women with ovarian cancer.